Amylyx Pharmaceuticals, Inc
Insiders
Last 12 monthsSales planned on beside the trades reported on , and whether each names a .
Planned ·
$9,432,545
24 notices · 544,195 sh
Oct 2025 to Oct 2026
Reported ·
$5,820,200
18 sales · 2 buys · $152,183 bought
Oct 2025 to Jun 2026
The two figures cover different periods.
None of the 18 reported sales carry the 10b5-1 box. Together they are 0.38% of the shares on issue.
under a no plan named▼ sale▲ buysize is dollars
Form 144 notices, newest first
2026-09-10Klee Justin B., Co-Chief Executive Officer$980,264
2026-09-10Frates James M, Chief Financial Officer$349,821
2026-09-10Bedrosian Camille L, Chief Medical Officer$324,868
2026-09-10Mazzariello Gina, Chief Legal Officer$309,506
2026-09-10Cohen Joshua B, Co-Chief Executive Officer$980,504
2026-07-09GINA MAZZARIELLO, Chief Legal Officer$536,400
2026-03-02Mazzariello Gina, Chief Legal Officer$99,379
Form 4, 2026-03-04: sold 6,844 at $14.52 Form 4 ↗
2026-03-02Cohen Joshua B, Co-Chief Executive Officer$424,120
Form 4, 2026-03-04: sold 29,282 at $14.48 Form 4 ↗
2026-03-02Klee Justin B., Co-Chief Executive Officer$423,760
Form 4, 2026-03-04: sold 29,282 at $14.47 Form 4 ↗
2026-03-02Bedrosian Camille L, Chief Medical Officer$94,205
Form 4, 2026-03-04: sold 6,461 at $14.58 Form 4 ↗
2026-03-02Frates James M, Chief Financial Officer$114,852
Form 4, 2026-03-04: sold 7,909 at $14.52 Form 4 ↗
2026-02-23Mazzariello Gina, Chief Legal Officer$48,352
Form 4, 2026-02-25: sold 3,419 at $14.14 Form 4 ↗
2026-02-02Cohen Joshua B, Co-Chief Executive Officer$227,593
Form 4, 2026-02-04: sold 15,500 at $14.68 Form 4 ↗
2026-02-02Klee Justin B., Co-Chief Executive Officer$227,617
Form 4, 2026-02-04: sold 15,500 at $14.69 Form 4 ↗
2026-02-02Mazzariello Gina, Chief Legal Officer$50,515
Form 4, 2026-02-04: sold 3,448 at $14.65 Form 4 ↗
2026-02-02Frates James M, Chief Financial Officer$52,097
Form 4, 2026-02-04: sold 3,557 at $14.65 Form 4 ↗
2026-01-16JUSTIN KLEE, Co-Chief Executive Officer$26,972
2026-01-16JOSHUA COHEN, Co-Chief Executive Officer$26,688
2026-01-15JOSHUA COHEN, Co-Chief Executive Officer$1,916,236
Form 4, 2026-01-20: sold 138,167 at $13.59 Form 4 ↗
2026-01-15JUSTIN KLEE, Co-Chief Executive Officer$1,916,236
Form 4, 2026-01-20: sold 138,188 at $13.58 Form 4 ↗
2026-01-06Frates James M, Chief Financial Officer$36,954
Form 4, 2026-01-08: sold 3,326 at $11.11 Form 4 ↗
2026-01-06Klee Justin B., Co-Chief Executive Officer$85,590
Form 4, 2026-01-08: sold 7,715 at $11.09 Form 4 ↗
2026-01-06Cohen Joshua B, Co-Chief Executive Officer$85,597
Form 4, 2026-01-08: sold 7,715 at $11.09 Form 4 ↗